Guggenheim Conference Sees Tarsus Shine
Tarsus presented at the Guggenheim conference, discussing xdemvy growth and pipeline widening, while other companies made waves at the Stifel 2026 Healthcare Conference

A number of companies presented at recent conferences, with Tarsus taking the stage at the Guggenheim conference to discuss its xdemvy growth and pipeline widening.
The presentation highlighted the company's focus on expanding its offerings.
Meanwhile, at the Stifel 2026 Healthcare Conference, several companies made presentations. Kailera broadened its obesity push, while Rhythm Pharmaceuticals discussed launch gains pace.
Palisade Bio focused on cash and trials, and Exelixis pushed zanzalintinib. Treace Medical Technologies and TransMedics also presented, expecting broader growth and widening their growth push, respectively.
Exelixis also presented at the Guggenheim Healthcare Innovation Conference, where it continued to push zanza.
## Why it matters The presentations at these conferences are important for companies to showcase their growth and development. They provide a platform for companies to share their progress and plans with investors and industry experts. The fact that these companies are presenting at such conferences highlights their commitment to innovation and expansion.
The conferences also provide an opportunity for companies to learn from each other and share best practices. The emphasis on upholding global quality benchmarks, research ethics, and organisational excellence in international technical conferences is crucial for the industry's growth and development.




